EMVO Announcement to Future On - Boarding

18.04.2018


EMVO Announcement to Future Onboarding Partners

NGDA : N-Ident Registrierung gestartet

03.04.2018


Die N-Ident Registrierung ist ab dem heutigen Tag über das Portal der NGDA möglich. Damit wird ein weiterer Meilenstein auf dem Weg zur fälschungssicheren Medikamentenabgabe erreicht. Ziel ist es, ab dem 9. Februar 2019 alle verschreibungspflichtigen Arzneimittel vor Abgabe an den Patienten einer Echtheitsprüfung unterziehen zu können. Dies geht aus …

EMVO Ankündigung der On-Boarding Partner

15.02.2018


EMVO kündigt On-Boarding Partner an

Status Report 2018 available

15.02.2018


One year before the Delegated Regulation applies, securPharm has released it’s new status report. 

New FAQ (version 9) of the EU Commission

13.02.2018


The EU Commission has published in february 2018 its new FAQ document (version 9) to the Falsified Medicines Directive 2011/62/EU and the Delegated Regulation (EU) 2016/161.

Ankündigung On-boarding Fee

15.12.2017


EMVO Kündigt On-boarding Gebühr an.

New FAQ (version 8) of the EU Commission

23.11.2017


The EU Commission has published in November 2017 its new FAQ document (Version 8) to the Falsified Medicines Directive 2011/62/EU and the Delegated Regulation (EU) 2016/161.

New FAQ (version 7) of the EU Commission

21.06.2017


The EU Commission has published in November 2017 its new FAQ document (version 7) to the Falsified Medicines Directive 2011/62/EU and the Delegated Regulation (EU) 2016/161.

Coding Rules 2.03 (incl. multi market packs)

16.05.2017


securPharm has released its new coding rules (v. 2.03). These now include detailed rules for multi market packs for the German market. For convenience there is also a changelog listing all changes to the former Version.